Clinical Trials Browser

Has results × saracatinib × Genitourinary × Clear all

NCT00513071 2018-04-19

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

28 enrolled 9 charts

Prostatic Neoplasms

NCT01267266 2015-04-01

Saracatinib in Treating Patients With Prostate Cancer

Phase 2 Terminated

31 enrolled 6 charts

Prostatic Neoplasms

NCT00558272 2013-05-27

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

Phase 2 Completed

139 enrolled 23 charts

BreastGenitourinarySarcoma

Bone Diseases, Bone Neoplasms, Breast Neoplasms, Prostatic Neoplasms